期刊文献+

以胆汁淤积性黄疸发病的新生儿脑腱黄瘤病1例报告 被引量:3

Neonatal cerebrotendinous xanthomatosis with cholestatic jaundice as the initial manifestation:A case report
下载PDF
导出
摘要 脑腱黄瘤病(cerbrotendinous xanthomatosis,CTX)是由甾醇-27-羟化酶(CYP27A1)基因突变引起的罕见常染色体隐性遗传病,其发病率低,世界范围内发病率为3/10万~5/10万,女性多于男性[1],临床表现多样,易被误诊、漏诊。目前报道的患者大多为成人,儿科报道的较少。现将1例利用全外显子组测序诊断的新生儿CTX报告如下。
作者 张茂燕 李林 吴成 ZHANG Maoyan;LI Lin;WU Cheng(Department of Gastroenterology,Anhui Provincial Children’s Hospital,Hefei 230051,China)
出处 《临床肝胆病杂志》 CAS 北大核心 2021年第2期411-413,共3页 Journal of Clinical Hepatology
关键词 黄疸 新生儿 黄瘤病 脑腱性 基因检测 Jaundice,Neonatal Xanthomatosis,Cerebrotendinous Genetic Testing
  • 相关文献

参考文献2

二级参考文献35

  • 1Verrips A, Hoefsloot LH, Steenbergen GC, et al. Clinical and molecular genetic characteristics of patients with cerebrotendinous xanthomatosis. Brain, 2000, 123 ( Pt 5): 908-919.
  • 2Lee MH, Hazard S, Carpten JD, et al. Fine-mapping, mutation analyses, and structuralmapping of cerebrotendinous xanthomatosis in U. S. pedigrees. Lipid Res, 2001,42(2): 159-169.
  • 3Pilo-de-la-Fuente B, Jimenez-Escrig A, Lorenzo JR, et al. Cerebrotendinous xanthomatosis in Spain: clinical, prognostic, and genetic survey. Eur J Neurol, 2011,18( 10): 1203-1211.
  • 4Mignani A, Gallus GN, Dotti MT, et al. A suspicion index for early diagnosis and treatment of cerebrotendinous xanthomatosis. Inherit Metab Dis, 2014,37(3): 421-429.
  • 5Clayton PT, Verrips A, Sistermans E, et al. Mutations in the sterol 27-hydroxylase gene (CYP27A) cause hepatitis of infancy as well as cerebrotendinous xanthomatosis. Inherit Metab Dis, 2002, 25(6):501-513.
  • 6von Bahr S, Bjorkhem I, Van't Hooft F, et al . Mutation in the sterol 27 -hydroxylase gene associated with fatal cholestasis in infancy. Pediatr Gastroenterol Nutr, 2005, 40(4) :481-486.
  • 7Pierre G, Setchell K, Blyth J, et al. Prospective treatment of cerebrotendinous xanthomatosis with cholic acid therapy.Inherit Metab Dis,2008, 31( S2) : 241-245.
  • 8Bjorkhem I,Hansson M. Cerebrotendinous xanthomatosis: an inborn error in bile acid synthesis with defined mutations but still a challenge. Biochem Biophys Res Commun, 2010, 396(1):4649.
  • 9Keren Z, Falik-Zaccai TC. Cerebrotendinous xanthomatosis(CTX): a treatable lipid storage disease. Pediatr Endocrinol Rev, 2009,7(1):6-11.
  • 10Fraidakis MJ. Psychiatric manifestations in cerebrotendinous xanthomatosis. Transl Psychiatry, 2013, 3, 301-302.

共引文献4

同被引文献43

引证文献3

二级引证文献11

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部